The UN health agency said on Friday that it had approved the use of the first diagnostic test for mpox, a key tool in countries battling outbreaks. Mpox, previously known as monkeypox, is caused ...
The initial patient was a young boy who has since recovered. The first diagnostic test for mpox has recently been approved by WHO as well. The test is called the Alinity m MPXV assay and it is ...
The United Nations agency approved the use of the vaccine in September as the first shot against mpox in adults, making it easier for badly hit African countries to access the vaccine. Children ...
The Food and Drug Administration has granted authorization of a COVID-19 and flu test that can be used without a prescription. The authorization, announced Monday, uses a nasal swab to detect ...
The World Health Organization (WHO) has approved the first mpox diagnostic test for emergency use, significantly boosting the diagnostic capacity in countries grappling with outbreaks of the disease.
The United Nations agency approved the use of the vaccine in September as the first shot against mpox in adults, making it easier for badly hit African countries to access the vaccine. Children ...
The World Health Organisation authorised Abbott Laboratories' mpox diagnostic test for emergency use on Oct 3, the first such approval in the agency's effort to bolster testing capabilities in ...
The World Health Organization (WHO) announced on Oct 4 (2024) that it had approved the use of the first diagnostic test for mpox, a key tool for countries battling outbreaks of this infectious ...
Another mpox vaccine, LC16, made by Japan's KM Biologics, can already be given to children, according to the Japanese regulator, although it requires a special kind of needle.
The World Health Organization (WHO) said on Friday that it has approved the first diagnostic test for mpox, marking a significant milestone in expanding global access to mpox testing. The approval ...
“This first mpox diagnostic test listed under the Emergency Use Listing procedure represents a significant milestone in expanding testing availability in affected countries,” said Dr. Yukiko ...